According to a 2024 report by Harvard Health, the Food and Drug Administration has approved a total of 10 GLP-1 medications for treating diabetes and obesity, with other applications like drug addiction still being studied
Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer
Lyu N, Zeng Y, Kong Y, Chen Q, Deng H, Ou S, et al
It is not a replacement for prescribed mental health treatment, and severe depression should always be managed by a licensed clinician
GadeaJSellesEMarcoMACoyPMatasCRomarRet al
Enhanced Lipid and Liver Biomarkers Higher doses reduce fasting triglycerides by more than 40% and decrease LDL and non-HDL cholesterol